HIGHLIGHTS
- who: Simone Mornese Pinna and collaborators from the Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy have published the research: Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series, in the Journal: Antibiotics 2022, 11, 1830. of 16/Dec/2022
- what: The authors report for the first time the pharmacokinetic cefiderocol in three critically ill patients undergoing CVVH with severe infections due to DTR-AB.
- future: Data and larger studies are needed to explore the possibility of reduced dosing to attain the optimal target of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.